Efrat Davash Riesenfeld

Efrat Davash Riesenfeld serves as the Chief Technology Officer at Exosomm, a company that is at the forefront of delivering bioactive compounds through advanced technological methods. Her work primarily involves the use of extracellular vesicles that are absorbed by intestinal epithelial cells. These vesicles release a payload of proteins, bioactive compounds, microRNAs, and active lipids once inside the cells, marking a significant development in the field.